Arete Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Arete Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $15,529 - $16,860	-22 Reduced 7.31%	279 $201,000
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $172,764 - $218,020	301 New	301 $207,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $165,601 - $223,129	-302 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $54,751 - $64,255	-92 Reduced 23.35%	302 $211,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $214,131 - $264,362	394 New	394 $247,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arete Wealth Advisors, LLC with notifications on news.